Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1988;11:160-165

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaillard, C. A.
Right arrow Articles by Mees, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaillard, C. A.
Right arrow Articles by Mees, E. J.

Hypertension, Vol 11, 160-165, Copyright © 1988 by American Heart Association


ARTICLES

Enalapril attenuates natriuresis of atrial natriuretic factor in humans

CA Gaillard, HA Koomans and EJ Mees
Department of Nephrology, University Hospital Utrecht, The Netherlands.

We studied the effect of converting enzyme inhibition with enalapril on the natriuresis observed after administration of atrial natriuretic factor (human ANF-[99-126], given as a 100-micrograms bolus i.v. injection) in eight healthy humans consuming a 100 mmol sodium diet. Without enalapril, sodium excretion rose from 127 +/- 19 (mean +/- SE) to 437 +/- 103 mumol/min in the first 20 minutes after ANF was administered. Clearance studies performed during maximal water diuresis indicated a rise in glomerular filtration rate (inulin clearance), free water clearance, phosphate, lithium, uric acid, and magnesium excretion. Four days of enalapril (20 mg b.i.d.) increased effective renal plasma flow (p-aminohippurate clearance) and reduced blood pressure (from 114/71 +/- 2/2 to 105/60 +/- 2/1 mm Hg). Under these conditions baseline sodium excretion was not different from the control study, but it rose less after ANF (from 117 +/- 22 to 242 +/- 63 mumol/min), and the increments in glomerular filtration rate, free water clearance, phosphate, lithium, uric acid, and magnesium were all blunted and nonsignificant. In addition, effective renal plasma flow tended to fall; this effect was not observed when ANF was given without enalapril. These results support the notion that the effects of ANF on renal hemodynamics and on tubular sodium handling depend on renal angiotensin II and that blood pressure reduction may interfere with the ANF-induced natriuresis.


This article has been cited by other articles:


Home page
HypertensionHome page
M. P. Boric and H. R. Croxatto
Inhibition of Atrial Natriuretic Peptide Excretory Action by Bradykinin
Hypertension, December 1, 1995; 26(6): 1167 - 1172.
[Abstract] [Full Text]


Home page
Arch Fam MedHome page
H. Gonzalez-Martinez, J. J. Gaspard, and D. V. Espino
Hyponatremia due to Enalapril in an Elderly Patient: A Case Report
Arch Fam Med, July 1, 1993; 2(7): 791 - 793.
[Abstract] [PDF]